How were Factor Therapeutics' earnings last quarter?

Factor Therapeutics Limited (ASX:FTT) issued its earnings results on Thursday, August, 8th. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter.

ASX:FTT

Factor Therapeutics (FTT) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free FTT Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 425,600 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Factor Therapeutics alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Factor Therapeutics

Factor Therapeutics Limited operates as a biotechnology company that focuses on developing and commercializing advanced wound care therapies. The company was formerly known as Tissue Therapies Limited and changed its name to Factor Therapeutics Limited in May 2016. Factor Therapeutics Limited was incorporated in 2002 and is based in Brisbane, Australia.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

FTT Stock News Headlines

July 25, 2021 | au.finance.yahoo.com

Anatara Lifesciences Limited (ANR.AX) Chair Transition

See More Headlines

Receive FTT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Factor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/08/2019
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: ASX:FTT
Previous Symbol: ASX:TIS
CUSIP: N/A
CIK: N/A
Web: factor-therapeutics.com
Phone: +61-7-33343900
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 19.84
Quick Ratio: 19.76

Sales & Book Value

Annual Sales: $1,794.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 1.00
Book Value: A$0.03 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 104,284,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Ms. Melanie Farris M.A.I.C.D.
ACIS) BComn, (AGIA, GradDip, ACG, Company Sec. & Non-Exec. Director

Key Competitors

View All Competitors

FTT Stock Analysis - Frequently Asked Questions

How were Factor Therapeutics' earnings last quarter?: Factor Therapeutics Limited (ASX:FTT) issued its earnings results on Thursday, August, 8th. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter.

This page (ASX:FTT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial